Visualizing the Cellular and Subcellular Distribution of Fms-like Tyrosine Kinase 3 (Flt3) and Other Neuronal Proteins Using Alkaline Phosphatase (AP) Immunolabeling

被引:0
作者
Yin, Yuqin [1 ,2 ,3 ]
He, Kathleen Z. [1 ]
Kirby, Jane [1 ,2 ]
Haque, Ishraq A. [4 ]
Tang, Xin [1 ,2 ,3 ]
机构
[1] Boston Childrens Hosp, Dept Neurosurg, 300 Longwood Ave, Boston, MA 02115 USA
[2] Boston Childrens Hosp, FM Kirby Neurobiol Ctr, 3 Blackfan Circle, Boston, MA 02115 USA
[3] Harvard Med Sch, Dept Neurosurg, Boston, MA 02115 USA
[4] Harvard Univ, Cambridge, MA 02138 USA
关键词
Flt3; brain development; AP-polymer histochemistry; weakly expressed proteins; histochemistry and immunofluorescent co-staining; Kir2.1; PSD95; human stem-cell derived neurons; ANTIBODIES; EXPRESSION;
D O I
10.3390/ijms26052284
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Precisely localizing the spatial distribution of proteins within various brain cell types and subcellular compartments, such as the synapses, is essential for generating and testing hypotheses to elucidate their roles in brain function. While the fms-like tyrosine kinase-3 (Flt3) has been extensively studied in the context of blood cell development and leukemia pathogenesis, its role in the brain remains poorly understood. Previous efforts to address this issue were hindered by the low expression levels of Flt3 and the limited sensitivity of the standard immunolabeling method, which were insufficient to reliably detect Flt3 protein in brain tissue. In this study, we systematically characterized Flt3 protein localization during brain development using a highly sensitive immunolabeling method based on alkaline phosphatase (AP) polymer biochemistry. This approach revealed a previously unrecognized neuron-selective Flt3 expression pattern in both mouse and human cerebella, with a developmental increase in total protein levels accompanied by a shift from a cytosolic to a dendritic subcellular distribution. Combining AP-polymer-based immunohistochemistry (AP-IHC) for Flt3 with conventional immunostaining of cell type marker proteins revealed parvalbumin- and calbindin-positive Purkinje cells to be the main cell type expressing Flt3 in the cerebellum. To validate the versatility of the AP-IHC method for detecting low-abundance neuronal proteins, we demonstrated robust labeling of Kir2.1, a potassium channel protein, in brain tissue sections from mouse, pig, and human samples. We further applied the AP-IHC method to human stem cell-derived neurons, effectively visualizing the postsynaptic density scaffold protein PSD95 within synapses. To our knowledge, this is the first study to employ an AP-IHC method combined with other standard immunofluorescent staining to co-detect weakly expressed neuronal proteins and other cellular markers in brain tissue and cultured neurons. Additionally, our findings uncover a previously unrecognized neuron-specific pattern of Flt3 expression in the cerebellum, laying the foundation for future mechanistic studies on its role in normal brain development and neurological disorders.
引用
收藏
页数:16
相关论文
共 21 条
[1]   Intracellular expression of FLT3 in Purkinje cells: implications for adoptive T-cell therapies [J].
Cakmak-Goeruer, Nese ;
Radke, Josefine ;
Rhein, Simone ;
Schumann, Elisa ;
Willimsky, Gerald ;
Heppner, Frank L. ;
Blankenstein, Thomas ;
Pezzutto, Antonio .
LEUKEMIA, 2019, 33 (04) :1039-1043
[2]  
DELAPEYRIERE O, 1995, DIFFERENTIATION, V58, P351, DOI 10.1007/s002580050094
[3]   Inwardly Rectifying Potassium Channel Kir2.1 and its "Kir-ious" Regulation by Protein Trafficking and Roles in Development and Disease [J].
Hager, Natalie A. ;
McAtee, Ceara K. ;
Lesko, Mitchell A. ;
O'Donnell, Allyson F. .
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 9
[4]   Cerebrospinal fluid Flt3 ligand level in patients with amyotrophic lateral sclerosis [J].
Ilzecka, J. .
ACTA NEUROLOGICA SCANDINAVICA, 2006, 114 (03) :205-209
[5]   Proper Application of Antibodies for Immunohistochemical Detection: Antibody Crimes and How to Prevent Them [J].
Ivell, Richard ;
Teerds, Katja ;
Hoffman, Gloria E. .
ENDOCRINOLOGY, 2014, 155 (03) :676-687
[6]   FMS-LIKE TYROSINE KINASE 3/FLT3: FROM BASIC SCIENCE TO CLINICAL IMPLICATIONS [J].
Kazi, Julhash U. ;
Ronnstrand, Lars .
PHYSIOLOGICAL REVIEWS, 2019, 99 (03) :1433-1466
[7]   FLT3 mutations in acute myeloid leukemia: Therapeutic paradigm beyond inhibitor development [J].
Kiyoi, Hitoshi ;
Kawashima, Naomi ;
Ishikawa, Yuichi .
CANCER SCIENCE, 2020, 111 (02) :312-322
[8]   FLT3 Inhibitors in Acute Myeloid Leukemia: Current Status and Future Directions [J].
Larrosa-Garcia, Maria ;
Baer, Maria R. .
MOLECULAR CANCER THERAPEUTICS, 2017, 16 (06) :991-1001
[9]  
Lowe D., 2024, StatPearls
[10]   Multiplex chromogenic immunohistochemistry to stain and analyze paraffin tissue sections from the mouse or human [J].
Maiques, Oscar ;
Sanz-Moreno, Victoria .
STAR PROTOCOLS, 2022, 3 (04)